Della Reese

Della Reese

Ask VT AI
View News Summary
  • Investors focus on growth firms with high insider ownership as a signal of confidence in future prospects across global markets.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Rams dominate Saints, Stafford shines with 4 TDs in 34-10 win
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Investors focus on growth firms with high insider ownership as a signal of confidence in future prospects across global markets.
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Rams dominate Saints, Stafford shines with 4 TDs in 34-10 win
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Della Reese